American Vanguard Corp (AVD) 14.65 $AVD American

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Vanguard Corp (AVD) 14.65 $AVD

American Vanguard Declares Quarterly Dividend
BusinessWire - Mon Jun 13, 8:00AM CDT
American Vanguard Corp. (NYSE:AVD) announced that its Board of Directors has declared a $0.01 cash dividend payment to be distributed on July 12, 2016 to shareholders of record as of June 30, 2016.
AVD: 14.65 (+0.09)

American Vanguard (AVD) Is in Oversold Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:36AM CDT
American Vanguard Corp. (AVD) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
AVD: 14.65 (+0.09)

International Flavors & Fragrances (IFF) Beats Q1 Earnings
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:36AM CDT
International Flavors & Fragrances Inc. (IFF) reported better-than-expected earnings for first-quarter 2016. Adjusted earnings came in at $1.47 per share, above the Zacks Consensus Estimate of $1.41.
IFF: 127.85 (-0.91), KMG: 26.65 (+0.12), DQ: 21.79 (-1.21), AVD: 14.65 (+0.09)

Downgrade Alert for American Vanguard (AVD)
Comtex SmarTrend(R) - Thu May 05, 3:12AM CDT
American Vanguard (NYSE:AVD) was downgraded from Buy to Neutral at Roth Capital today. The stock closed yesterday at $13.27 on volume of 990,000 shares, above average daily volume of 219,000. Over the past year, American Vanguard has traded in a range of $9.63 to $17.41 and closed yesterday at $13.27, 38% above that low. The 200-day and 50-day moving averages have moved 0.30% higher and 1.13% higher over the past week, respectively.
AVD: 14.65 (+0.09)

American Vanguard Reports First Quarter 2016 Results
BusinessWire - Tue May 03, 3:05PM CDT
American Vanguard Corporation (NYSE:AVD), today announced financial results for the quarter ended March 31, 2016.
AVD: 14.65 (+0.09)

American Vanguard Shares Up 45.4% Since SmarTrend's Buy Recommendation (AVD)
Comtex SmarTrend(R) - Fri Apr 29, 12:58PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 3 months, American Vanguard has returned 45.44% as of today's recent price of $16.90.
AVD: 14.65 (+0.09)

Uptrend Call Working As American Vanguard Stock Rises 39.8% (AVD)
Comtex SmarTrend(R) - Thu Apr 21, 12:54AM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 3 months, American Vanguard has returned 39.76% as of today's recent price of $16.24.
AVD: 14.65 (+0.09)

Shares of AVD Up 34.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 13, 1:27PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 2 months, American Vanguard has returned 34.77% as of today's recent price of $15.66.
AVD: 14.65 (+0.09)

American Vanguard Shares Up 37.3% Since SmarTrend's Buy Recommendation (AVD)
Comtex SmarTrend(R) - Tue Mar 29, 1:19PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 2 months, American Vanguard has returned 37.26% as of today's recent price of $15.95.
AVD: 14.65 (+0.09)

American Vanguard Up 37.5% Since SmarTrend Uptrend Call (AVD)
Comtex SmarTrend(R) - Tue Mar 22, 1:18AM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 2 month, American Vanguard has returned 37.52% as of today's recent price of $15.98.
AVD: 14.65 (+0.09)

UK Pesticides Market Growth of 3.84% CAGR by 2020 - Analysis, Technologies & Forecast Report 2015-2020 - Key Vendors: American Vanguard Corp, BASF SE, Cheminova - Research and Markets
BusinessWire - Tue Mar 08, 8:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/93m7p7/united_kingdom) has announced the addition of the "United Kingdom Pesticides Market - Growth, Trends And Forecasts (2015 - 2020)" report to their offering.
AVD: 14.65 (+0.09)

Air Products Gets PRISM Membrane Separators Supply Deal
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 12:35PM CST
Air Products and Chemicals, Inc. (APD) said that its PRISM Membranes division has secured an order to deliver a large number of membrane separators to the Ningdong Energy and Chemical Industry Base in Ningxia, China.
DQ: 21.79 (-1.21), AVD: 14.65 (+0.09), APD: 144.78 (-1.61)

American Vanguard Has Returned 35.2% Since SmarTrend Recommendation (AVD)
Comtex SmarTrend(R) - Thu Mar 03, 6:32PM CST
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 4 weeks, American Vanguard has returned 35.20% as of today's recent price of $15.71.
AVD: 14.65 (+0.09)

American Vanguard's (AVD) Subsidiary Invests in Bi-PA
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 2:25PM CST
American Vanguard's (AVD) fully-owned subsidiary, AMVAC-Netherlands BV, has invested in Biological Products for Agriculture.
DQ: 21.79 (-1.21), GSM: 8.13 (+0.18), AVD: 14.65 (+0.09), FSI: 1.69 (+0.14)

Albemarle (ALB) Rewards Investors with 5% Hike in Dividend
Zacks Equity Research - Zacks Investment Research - Tue Mar 01, 2:25PM CST
Chemical maker Albemarle Corporation (ALB) has announced a 5% increase in its quarterly dividend to 30.5 cents per share from 29 cents paid earlier.
ALB: 78.49 (-1.34), AVD: 14.65 (+0.09)

BHP Billiton's (BHP) Prospects Bright amid Market Headwinds
Zacks Equity Research - Zacks Investment Research - Tue Mar 01, 2:20PM CST
On Feb 29, 2016, we issued an updated research report on premium basic materials company, BHP Billiton Limited (BHP).
BHP: 26.88 (+0.15), AVD: 14.65 (+0.09), URG: 0.56 (-0.04)

PPG Industries-Bridgestone Project Gets Funds from DOE
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 3:15PM CST
PPG Industries Inc. (PPG) said that the U.S. Department of Energy is funding its $1.25 million collaborative project with Bridgestone Americas, Inc.
AVD: 14.65 (+0.09), PPG: 107.99 (-1.25)

PPG to Showcase Substrate-Protection Products at ECOAT16
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 4:30PM CST
PPG Industries (PPG) will showcase a range of integrated substrate-protection products and also present five technical papers at ECOAT16.
AVD: 14.65 (+0.09), PPG: 107.99 (-1.25)

LyondellBasell (LYB) Wraps Up Petroken Unit Sale to GIP
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 3:04PM CST
LyondellBasell (LYB) has completed the sale of its Argentina-based fully-owned unit Petroken to Grupo Inversor Petroquimica S.L.
KMG: 26.65 (+0.12), LYB: 79.51 (-0.96), AVD: 14.65 (+0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading